SCHEMBL22002807

SCHEMBL22002807

CC(C)(O)c1csc([SH](=N)=O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23569351 0.70
SCHEMBL9414397 0.67 TYR (0.30)
SCHEMBL129653 0.67 CHRM3 (0.41)
SCHEMBL12615412 0.66 ALDH1A1 (0.32)
SCHEMBL20933012 0.66 MAPK14 (0.32)
SCHEMBL129652 0.66
SCHEMBL22020012 0.66 CA2 (0.32)
SCHEMBL16742869 0.65 ALDH1A1 (0.31)
SCHEMBL22013670 0.64 CA2 (0.38)
SCHEMBL7144702 0.63 CA2 (0.51)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021093820-A1 AMIDE DERIVATIVE AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINE 成都百裕制药股份有限公司 2021-05-20 WO disclosed
US-10654816-B2 Compounds and compositions for treating conditions associated with NLRP activity NOVARTIS INFLAMMASOME RESEARCH, INC. (US) 2020-05-19 US disclosed